Pulmatrix
PULM
12 hedge funds and large institutions have $566K invested in Pulmatrix in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 0 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% more funds holding
Funds holding: 12 → 12 (0)
2.15% less ownership
Funds ownership: 10.48% → 8.33% (-2.1%)
27% less capital invested
Capital invested by funds: $777K → $566K (-$211K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.9K |
| 2 |
Renaissance Technologies
New York
|
+$11.6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$496 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$96 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$186K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.02K |
PULM Hedge Fund Activity: Q4 2023 in Review
12 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Pulmatrix (PULM) for Q4 2023, worth a combined $566K — down 27% from $777K a quarter earlier.
Fund positioning in PULM was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $25.9K. The largest seller was Sabby Management, cutting an estimated $186K.
- 12 institutional investors held Pulmatrix (PULM) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $566K of Pulmatrix stock for Q4 2023, down 27% quarter-over-quarter.
- 0 funds opened new Pulmatrix positions in Q4 2023 and 0 closed out.
- The largest Pulmatrix buyer in Q4 2023 was Vanguard Group, an estimated $25.9K added.
- The largest Pulmatrix seller in Q4 2023 was Sabby Management, an estimated $186K sold.
Based on aggregated 13F filings for Q4 2023.